[2]Chiti, F.; Dobson, C. M., Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annual review of biochemistry 2017, 86, 27-68.
[3]Sipe, J. D.; Benson, M. D.; Buxbaum, J. N.; Ikeda, S. i.; Merlini, G.; Saraiva, M.J.; Westermark, P., Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis.Amyloid 2012, 19 (4), 167-170.
[4]Benson, M. D.; Buxbaum, J. N.; Eisenberg, D. S.; Merlini, G.; Saraiva, M. J.; Sekijima, Y.; Sipe, J. D.; Westermark, P., Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid 2018, 25 (4), 215-219.
[5]Hashimoto, M.; Rockenstein, E.; Crews, L.; Masliah, E., Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer’s and Parkinson’s diseases. Neuromolecular medicine 2003, 4 (1), 21-35.